Acth 1-24 (tetracosactide Acetate)
Generic Name: acth 1-24 (tetracosactide acetate)
Dosage form: POWDER. Active ingredients: COSYNTROPIN HEXAACETATE (1 g/g). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: COSYNTROPIN HEXAACETATE (1 g/g). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Agnus, Aralia Quinquefolia, Baryta Carb., Berber. Vulg., Bryonia, Caladium Seguinum, Cantharis, Causticum, Chelidonium Majus, Cinchona, Conium, Gaultheria Procumbens, Graphites, Kali Carb., Lycopodium, Nux Vom., Onosmodium Virginianum, Phosphorus, Sabal, Selenium, Sepia, Silicea, Staphysag., Hydrastis, Thuja Occ
agnus, aralia quinquefolia, baryta carb., berber. vulg., bryonia, caladium seguinum, cantharis, causticum, chelidonium majus, cinchona, conium, gaultheria procumbens, graphites, kali carb., lycopodium, nux vom., onosmodium virginianum, phosphorus, sabal, selenium, sepia, silicea, staphysag., hydrastis, thuja occ
Non-Standardized Plant Allergenic Extract [EPC]
OTC - PURPOSE SECTION Formulated for associated symptoms such as decreased desire, dryness, impotence, anxiety and hypersexuality.
Doravirine And Islatravir Monohydrate
doravirine and islatravir monohydrate
Dosage form: TABLET, FILM COATED. Active ingredients: DORAVIRINE (100 mg/1); ISLATRAVIR MONOHYDRATE (.25 mg/1). Category: DRUG FOR FURTHER PROCESSING.
Cyclopentolate Hydrochloride
cyclopentolate hydrochloride
Rx Only DESCRIPTION: CYCLOGYL ® (cyclopentolate hydrochloride ophthalmic solution, USP) is an anticholinergic prepared as a sterile, borate buffered, solution for topical ocular use. It is supplied in three strengths. The active ingredient is represented by the structural formula: Each mL of CYCLOGYL ® (cyclopentolate hydrochloride ophthalmic solution, USP) contains: Active: cyclopentolate hydrochloride 0.5%, 1% or 2%. Preservative: benzalkonium chloride 0.01%.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.